Confirming Uncomplicated Cystitis
Placeholder: dysuria, frequency, urgency without fever confirm simple cystitis.
- Acute: Typical onset (Placeholder short note on symptom onset.)
- No: Fever present (Placeholder note distinguishing pyelonephritis.)
- Non-pregnant women: Population (Placeholder note on typical patient group.)
- No: Imaging needed (Placeholder note on diagnostic workup.)
Clinical criteria for uncomplicated cystitis
Placeholder text describing diagnostic criteria in one short sentence.
Reviewing Local Resistance Patterns
Placeholder: local antibiogram guides whether TMP-SMX remains a safe choice.
- 20%: Resistance threshold (Placeholder note on guideline cutoff.)
- Antibiogram: Data source (Placeholder note on regional lab data.)
- Annual: Update frequency (Placeholder note on surveillance cadence.)
- TMP-SMX: Affected drug (Placeholder note on resistance-sensitive agent.)
Using resistance data to guide therapy
Placeholder text on how resistance rates shift first-line choice.
Screening Allergy History
Placeholder: sulfa allergy history rules out TMP-SMX as an option.
- Sulfonamide: Key allergen (Placeholder note on relevant allergy class.)
- Low: Cross-reactivity (Placeholder note on beta-lactam overlap.)
- Patient history: Screening method (Placeholder note on how allergy is captured.)
- Anaphylaxis flag: Severity check (Placeholder note on severity stratification.)
Allergy documentation before prescribing
Placeholder text on confirming allergy severity and drug class.
Filtering Out Unsuitable Agents
Placeholder: agents failing resistance or allergy checks are removed.
- 2: Filter inputs (Placeholder note on resistance and allergy inputs.)
- 3: Candidates start (Placeholder note on initial drug pool.)
- 1-2: Typical survivors (Placeholder note on filtered candidate count.)
- Rule-based: Decision logic (Placeholder note on elimination logic.)
Elimination logic across candidates
Placeholder text describing why an agent gets eliminated.
Selecting the First-Line Agent
Placeholder: highest-ranked surviving agent becomes the first-line prescription.
- Nitrofurantoin: Default first-line (Placeholder note on typical preferred agent.)
- Fosfomycin: Alt option (Placeholder note on single-dose alternative.)
- TMP-SMX: Conditional option (Placeholder note on resistance-dependent choice.)
- 3-7 days: Course length (Placeholder note on typical treatment duration.)
Finalizing the prescription decision
Placeholder text on confirming the recommended first-line agent.
Placeholder: recommendation updates live with resistance and allergy sliders.